Peptides from antibodies to DNA elicit cytokine release from peripheral blood mononuclear cells of patients with systemic lupus erythematosus: relation of cytokine pattern to disease duration.

Autor: Kalsi, J. K.¹, Grossman, J.¹, Kim, J.¹, Sieling, P.², Gjertson, D. W.³, Reed, E. F.³, Ebling, F. M.¹, Linker-Israeli, M.⁴, Hahn, B. H.¹ bhahn@mednet.ucla.edu

Publikováno v: Lupus. 2004, Vol. 13 Issue 7, p490-500. 11p. 2 Charts, 5 Graphs.

Interplay of four Idiotypes and Interaction with Autoantibodies in Lupus Patients, their Relatives and their Spouses

Autor: Youinou, P., Isenberg, D. A., Kalsi, J. K., Dugoujon, J.-M., Ravirajan, C. T., Muller, S., Blanco, F., Piette, J.-C., Guillevin, L., Jouquan, J., Semana, G., Salmon, D., Shoenfeld, Y., Bach, J.-F.

Publikováno v: Journal of Autoimmunity; December, 1996, Vol. 9 Issue: 6 p767-775, 9p

Feedback regulation of antibody production: a role in rheumatoid arthritis?

Autor: Kalsi, J K, Hall, N D

Publikováno v: Annals of the Rheumatic Diseases; Nov1991, Vol. 50 Issue 11, p833-835, 3p

Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS.

Autor: Taylor JA; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Burnell M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Ryan A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Karpinskyj C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Kalsi JK; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.; Department Epidemiology and Public Health, Institute of Epidemiology and Health Care, UCL, London, UK., Taylor H; Department of Surgery and Cancer, Imperial College Healthcare NHS Trust, London, UK., Apostolidou S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Sharma A; Department of Obstetrics and Gynaecology, University Hospital of Wales, Cardiff, UK., Manchanda R; Barts Health NHS Trust and Wolfson Institute of Preventive Medicine, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK., Woolas R; Department of Gynaecological Oncology, Queen Alexandra Hospital, Portsmouth, UK., Campbell S; Create Fertility, London, UK., Parmar M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Singh N; Department of Cellular Pathology, Barts Health NHS Trust, London, UK., Jacobs IJ; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.; University of New South Wales, Sydney, NSW, Australia., Menon U; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Gentry-Maharaj A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.

Publikováno v: BJOG : an international journal of obstetrics and gynaecology [BJOG] 2022 Jan; Vol. 129 (1), pp. 110-118. Date of Electronic Publication: 2021 Oct 17.

The role of VH determinants in systemic lupus erythematosus.

Autor: Kalsi JK; Centre for Rheumatology Research, Windeyer Institute for Medical Sciences, University College London, London, UK. jkalsizz@hotmail.com, Hahn BH

Publikováno v: Lupus [Lupus] 2002; Vol. 11 (12), pp. 878-84.